SFFS
BIIB icon

Stonehage Fleming Financial Services’s Biogen BIIB Stock Holding History

Stonehage Fleming Financial Services’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-265
Closed -$83K – 296
2016
Q3 		$83K Buy
+265
New +$78.5K ﹤0.01% 243

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Stonehage Fleming Financial Services's BIIB Position: Q4 2016 in Review

Stonehage Fleming Financial Services sold out of Biogen (BIIB) in Q4 2016, closing a stake of 265 shares — an estimated $83K sold.

Stonehage Fleming Financial Services first reported a position in BIIB in Q3 2016 and held it in 1 quarter. The position peaked at $83K in Q3 2016. 1,026 funds tracked by Wall St. Rank hold BIIB as of Q4 2016.

  • Stonehage Fleming Financial Services reported no remaining Biogen position as of Q4 2016 after selling out during the quarter.
  • Stonehage Fleming Financial Services sold 265 Biogen shares in Q4 2016, an estimated $83K.
  • Stonehage Fleming Financial Services first reported a position in Biogen in Q3 2016 and held it in 1 quarter.
  • Stonehage Fleming Financial Services's Biogen position peaked at $83K in Q3 2016.
  • 1,026 funds tracked by Wall St. Rank held Biogen as of Q4 2016.

Based on Stonehage Fleming Financial Services's 13F filing for Q4 2016, filed 11 Oct 2019.